Showing results (151-160 of 212) with videos related to
Sort By:
Pageof 22
Frontiers in Pharmacology|November 23, 2017
Risk Factors of Hypersensitivity to Carboplatin in Patients with Gynecologic MalignanciesYu-Hsiao Tai, Yi-Jou Tai, Heng-Cheng Hsu, et al.American Journal of Nephrology|February 27, 2022
Pentraxin 3 Predicts Arteriovenous Fistula Functional Patency Loss and Mortality in Chronic Hemodialysis PatientsHeng-Cheng Tsai, Shuo-Ming Ou, Chih-Cheng Wu, et al.Cellular Immunology|April 3, 2012
Tolerogenic dendritic cells generated by RelB silencing using shRNA prevent acute rejectionHeng-cheng Zhu, Tao Qiu, Xiu-heng Liu, et al.Scientific Reports|October 7, 2016
Characterization of maize roothairless6 which encodes a D-type cellulose synthase and controls the switch from bulge formation to tip growthLi Li, Stefan Hey, Sanzhen Liu, et al.World Journal of Gastroenterology|February 2, 2012
Roux-en-Y reconstruction does not require gastric decompression after radical distal gastrectomyCheng-Jueng Chen, Tsang-Pai Liu, Jyh-Cherng Yu, et al.International Journal of Environmental Research and Public Health|October 1, 2020
Outcome and Subsequent Pregnancy after Fertility-Sparing Surgery of Early-Stage Cervical CancersChia-Yi Lee, Yu-Li Chen, Ying-Cheng Chiang, et al.International Immunopharmacology|January 24, 2012
Lentiviral-mediated shRNA against RelB induces the generation of tolerogenic dendritic cellsTao Qiu, Heng-cheng Zhu, Xiu-heng Liu, et al.Reviews in Cardiovascular Medicine|July 30, 2024
Performance of the Risk Scores for Predicting In-Hospital Mortality in Patients with Acute Coronary Syndrome in a Chinese CohortLin Bai, Yi-Ming Li, Bo-Sen Yang, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|July 14, 2026
Glucagon-like peptide-1 receptor agonist and post-operative opioid consumption in gynecologic surgeryPaula Mateo-Kubach, Gemma Mancebo Moreno, Kamilla L David, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 18, 2025
Hormone replacement therapy in gynecologic cancer: oncologic safety and alternative therapiesAna Luzarraga Aznar, Osnat Elyashiv, Susan Dababou, et al.Pageof 22